Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial
Titel:
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial
Auteur:
Gansevoort, Ronald T. Hariri, Ali Minini, Pascal Ahn, Curie Chapman, Arlene B. Horie, Shigeo Knebelmann, Bertrand Mrug, Michal Ong, Albert C.M. Pei, York P.C. Torres, Vicente E. Modur, Vijay Antonshchuk, Igor Perrone, Ronald D.